Attention Deficit/Hyperactivity Disorder-Derived Coding Variation in the Dopamine Transporter Disrupts Microdomain Targeting and Trafficking Regulation
Open Access
- 18 April 2012
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 32 (16) , 5385-5397
Abstract
Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed disorder of school-age children. Although genetic and brain-imaging studies suggest a contribution of altered dopamine (DA) signaling in ADHD, evidence of signaling perturbations contributing to risk is largely circumstantial. The presynaptic, cocaine- and amphetamine (AMPH)-sensitive DA transporter (DAT) constrains DA availability at presynaptic and postsynaptic receptors following vesicular release and is targeted by the most commonly prescribed ADHD therapeutics. Using polymorphism discovery approaches with an ADHD cohort, we identified a hDAT (human DAT) coding variant, R615C, located in the distal C terminus of the transporter, a region previously implicated in constitutive and regulated transporter trafficking. Here, we demonstrate that, whereas wild-type DAT proteins traffic in a highly regulated manner, DAT 615C proteins recycle constitutively and demonstrate insensitivity to the endocytic effects of AMPH and PKC (protein kinase C) activation. The disrupted regulation of DAT 615C parallels a redistribution of the transporter variant away from GM1 ganglioside- and flotillin1-enriched membranes, and is accompanied by altered CaMKII (calcium/calmodulin-dependent protein kinase II) and flotillin-1 interactions. Using C-terminal peptides derived from wild-type DAT and the R615C variant, we establish that the DAT 615C C terminus can act dominantly to preclude AMPH regulation of wild-type DAT. Mutagenesis of DAT C-terminal sequences suggests that phosphorylation of T613 may be important in sorting DAT between constitutive and regulated pathways. Together, our studies support a coupling of DAT microdomain localization with transporter regulation and provide evidence of perturbed DAT activity and DA signaling as a risk determinant for ADHD.Keywords
This publication has 67 references indexed in Scilit:
- Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DATNature Neuroscience, 2011
- Palmitoylation Controls Dopamine Transporter Kinetics, Degradation, and Protein Kinase C-dependent RegulationJournal of Biological Chemistry, 2011
- Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine BindingJournal of Biological Chemistry, 2010
- Identification and Validation of Novel Spinophilin-associated Proteins in Rodent Striatum Using an Enhanced ex Vivo Shotgun Proteomics ApproachMolecular & Cellular Proteomics, 2010
- Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystoniaJournal of Clinical Investigation, 2009
- Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine EffluxMolecular Pharmacology, 2008
- Dopamine transporter endocytic determinants: Carboxy terminal residues critical for basal and PKC-stimulated internalizationMolecular and Cellular Neuroscience, 2008
- Going with the Flow: Trafficking‐Dependent and ‐Independent Regulation of Serotonin TransportTraffic, 2008
- Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independentNeuropharmacology, 2008
- Three Ubiquitin Conjugation Sites in the Amino Terminus of the Dopamine Transporter Mediate Protein Kinase C–dependent Endocytosis of the TransporterMolecular Biology of the Cell, 2007